10:23 AM EST - Plus Products Inc. : Announced that it has entered into a partnership with CannRx Biosciences, a leading Israeli cannabis firm in the boutique field of cannabis-based botanical medicine, to enhance the onset of the Company’s products. CannRx, operating out of their research lab in Tel Aviv, Israel, has created a solid nano-particle water soluble technology, using proteins to improve the bioavailability of cannabinoids and terpenes. CannRx has replicated the body’s natural and sophisticated protein-based transport system which facilitates delivery of active compounds through the body and tailored this process specifically for cannabinoids. “We are excited about the relationship with CannRx and their research team, and the opportunity to further advance the science behind our products,” stated Jake Heimark, CEO and Co-founder of PLUS. “Israel leads the way in cannabis research and the industry is ripe for innovation. We believe that consumers want to take control of how quickly they can feel the effects of cannabis. Our goal is to put them in the driver’s seat for the experience, from start to finish.” Plus Products Inc.
shares C.PLUS are trading up 2 cents at $0.86.
